Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Japanese Patients 60 Years or Older With Atherosclerotic Risk FactorsYasuo Ikeda, Naoki Ishizuka, Kazuyuki Shimada et al.|JAMA|2014Cited by 304
Hemostatic Effects of Phospholipid Vesicles Carrying Fibrinogen γ Chain Dodecapeptide in Vitro and in VivoYosuke Okamura, Shinji Takeoka, H Maruyama et al.|Bioconjugate Chemistry|2005Cited by 62
Aspirin for Stroke Prevention in Elderly Patients With Vascular Risk FactorsShinichiro Uchiyama, Yasuo Ikeda, Masayasu Matsumoto et al.|Stroke|2016Cited by 30